Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion

Biochemistry

Volumn 44, Issue 36, 2005, Pages 12009-12021

  Sun, Jin Peng ^a   Wang, Wei Qing ^a   Yang, Heyi ^a   Liu, Sijiu ^a   Liang, Fubo ^a   Fedorov, Alexander A ^a   Almo, Steven C ^a   Zhang, Zhong Yin ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CATALYSIS; CELL CULTURE; CHEMICAL BONDS; HYDROGEN PEROXIDE; OXYGEN; TUMORS;

BIOCHEMICAL PROPERTIES; PHOSPHATASE OF REGENERATING LIVER (PRL); PRENYLATION; TUMOR INVASION;

PHOSPHATES;

CDC14 PHOSPHATASE; CYSTEINE; DISULFIDE; HYDROGEN PEROXIDE; MUTANT PROTEIN; PHOSPHATASE; PROTEIN PRL1; REACTIVE OXYGEN METABOLITE; SULFATE; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; CANCER INVASION; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN HEK293; CRYSTAL STRUCTURE; CRYSTALLIZATION; DISULFIDE BOND; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; HUMAN; HUMAN CELL; KINETICS; MEMBRANE BINDING; POLYMERIZATION; PRENYLATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; DISULFIDES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE-PHOSPHATASE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 24644519820     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0509191     Document Type: Article

References (63)

1. Hunter, T. (1998) The phosphorylation of proteins on tyrosine: its role in cell growth and disease, Philos. Trans. R. Soc. London, Ser. B 353, 583-605.
2. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., and Mustelin, T. (2004) Protein tyrosine phosphatases in the human genome, Cell 117, 699-711.
3. Zhang, Z.-Y. (2001) Protein tyrosine phosphatases: prospects for therapeutics, Curr. Opin. Chem. Biol. 5, 416-423.
4. Diamond, R. H., Cressman, D. E., Laz, T. M., Abrams, C. S., and Taub, R. (1994) PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth, Mol. Cell. Biol. 14, 3752-3762.
5. Cates, C. A., Michael, R. L., Stayrook, K. R., Harvey, K. A., Burke, Y. D., Randall, S. K., Crowell, P. L., and Crowell, D. N. (1996) Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatase, Cancer Lett. 110, 49-55.
6. Zeng, Q., Si, X., Horstmann, H., Xu, Y., Hong, W., and Pallen, C. J. (2000) Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome, J. Biol. Chem. 275, 21444-21452.
7. Bardelli, A., Saha, S., Sager, J. A., Romans, K. E., Xin, B., Markowitz, S. D., Lengauer, C., Velculescu, V. E., Kinzler, K. W., and Vogelstein, B. (2003) PRL-3 expression in metastatic cancers, Clin. Cancer Res. 9, 5607-5615.
8. Wang, J., Kirby, C. E., and Herbst, R. (2002) The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis, J. Biol. Chem. 277, 46659-46668.
9. Diamond, R. H., Peters, C., Jung, S. P., Greenbaum, L. E., Haber, B. A., Silberg, D. G., Traber, P. G., and Taub, R. (1996) Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine, Am. J. Physiol. 271, G121-129.
10. Kong, W., Swain, G. P., Li, S., and Diamond, R. H. (2000) PRL-1 PTPase expression is developmentally regulated with tissue-specific patterns in epithelial tissues, Am. J. Physiol. 279, G613-621.
11. Rundle, C. H., and Kappen, C. (1999) Developmental expression of the murine Prl-1 protein tyrosine phosphatase gene, J. Exp. Zool. 253, 612-617.
12. Matter, W. F., Estridge, T., Zhang, C., Belagaje, R., Stancato, L., Dixon, J., Johnson, B., Bloem, L., Pickard, T., Donaghue, M., Acton, S., Jeyaseelan, R., Kadambi, V., and Vlahos, C. J. (2001) Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling, Biochem. Biophys. Res. Commun. 283, 1061-1068.
13. Zeng, Q., Dong, J. M., Guo, K., Li, J., Tan, H. X., Koh, V., Pallen, C. J., Manser, E., and Hong, W. (2003) PRL-3 and PRL-1 promote cell migration, invasion, and metastasis, Cancer Res. 63, 2716-2722.
14. Werner, S. R., Lee, P. A., DeCamp, M. W., Crowell, D. N., Randall, S. K., and Crowell, P. L. (2003) Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1) by PRL tyrosine phosphatases. Cancer Lett. 202, 201-211.
15. Wang, Q., Holmes, D. I., Powell, S. M., Lu, Q. L., and Waxman, J. (2002) Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene, Cancer Lett. 175, 63-69.
16. Saha, S., Bardelli, A., Buckhaults, P., Velculescu, V. E., Rago, C., St. Croix, B., Romans, K. E., Choti, M. A., Lengauer, C., Kinzler, K. W., and Vogelstein, B. (2001) A phosphatase associated with metastasis of colorectal cancer, Science 294, 1343-1346.
17. Kato, H., Semba, S., Miskad, U. A., Seo, Y., Kasuga, M., and Yokozaki, H. (2004) High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases, Clin. Cancer Res. 10, 7318-7328.
18. Miskad, U. A., Semba, S., Kato, H., and Yokozaki, H. (2004) Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis, Pathobiology 71, 176-184.
19. Wu, X., Zeng, H., Zhang, X., Zhao, Y., Sha, H., Ge, X., Zhang, M., Gao, X., and Xu, Q. (2004) Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells, Am. J. Pathol 164, 2039-2054.
20. Guo, K., Li, J., Tang, J. P., Koh, V., Gan, B. Q., and Zeng, Q. (2004) Catalytic domain of PRL-3 plays an essential role in tumor metastasis: formation of PRL-3 tumors inside the blood vessels, Cancer Biol. Ther. 3, 945-951.
21. Kozlov, G., Cheng, J., Ziomek, E., Banville, D., Gehring, K., and Ekiel, I. (2004) Structural insights into molecular function of the metastasis-associated phosphatase PRL-3, J. Biol. Chem. 279, 11882-11889.
22. Jeong, D. G., Kim, S. J., Kim, J. H., Son, J. H., Park, M. R., Lim, S. M., Yoon, T. S., and Ryu, S. E. (2005) Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms, J. Mol. Biol. 345, 401-413.
23. Zhang, Z.-Y., and Van Etten, R. L. (1991) Pre-steady-state and steady-state kinetic analysis of the low molecular weight phosphotyrosyl protein phosphatase from bovine heart, J. Biol. Chem. 266, 1516-1525.
24. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol. 176, 307-326.
25. Terwilliger, T. C. (1994) MAD phasing: Bayesian estimates of F(A), Acta Crystallogr., Sect. D: Biol. Crystallogr. 50, 11-16.
26. Terwilliger, T. C. (1994) MAD phasing: treatment of dispersive differences as isomorphous replacement information, Acta Crystallogr., Sect. D: Biol. Crystallogr. 50, 17-23.
27. Terwilliger, T. C., and Berendzen, J. (1996) Correlated phasing of multiple isomorphous replacement data, Acta Crystallogr., Sect. D: Biol. Crystallogr. 52, 749-757.
28. Jones, T. A., and Kjeldgaard, M. (1993) O, version 5.9, Uppsala University, Uppsala.
29. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination, Acta Crystallogr., Sect. D: Biol. Crystallogr. 54, 905-921
30. Wang, W.-Q., Bembenek, J., Gee, K. R., Yu, H., Charbonneau, H., and Zhang, Z.-Y. (2004) Kinetic and Mechanistic Studies of a Cell Cycle Protein Phosphatase Cdc14, J. Biol. Chem. 279, 30459-30468.
31. Holm, L., and Sander, C (1993) Protein structure comparison by alignment of distance matrices. J. Mol. Biol. 233, 123-138.
32. Gray, C. H., Good, V. M., Tonks, N. K., and Barford, D. (2003) The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase, EMBO J. 22, 3524-3535.
33. Song, H., Hanlon, N., Brown, N. R., Noble, M. E., Johnson, L. N., and Barford, D. (2001) Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2, Mol. Cell 7, 615-626.
34. Lee, J. O., Yang, H., Georgescu, M. M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., and Pavletich, N. P. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association, Cell 99, 323-334.
35. Yuvaniyama, J., Denu, J. M., Dixon, J. E., and Saper, M. A. (1996) Crystal structure of the dual specificity protein phosphatase VHR, Science 272, 1328-1331.
36. Kim, K. A., Song, J. S., Jee, J., Sheen, M. R., Lee, C., Lee, T. G., Ro, S., Cho, J. M., Lee, W., Yamazaki, T., Jeon, Y. H., and Cheong, C. (2004) Structure of human PRL-3, the phosphatase associated with cancer metastasis, FEBS Lett. 565, 181-187.
37. Hancock, J. F., Paterson, H., Marshall, C. J. (1990) A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane, Cell 63, 133-139.
38. Murray, D., Ben-Tal, N., Honig, B., and McLaughlin, S. (1997) Electrostatic interaction of myristoylated proteins with membranes: simple physics, complicated biology, Structure 5, 985-989.
39. Choy, E., Chiu, V. K., Silletti, J., Feoktistov, M., Morimoto, T., Michaelson, D., Ivanov, I. E., and Philips, M. R. (1999) Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi, Cell 98, 69-80.
40. Zhang, Z.-Y. (1995) Kinetic and mechanistic characterization of a mammalian protein tyrosine phosphatase, PTP1, J. Biol. Chem. 270, 11199-11204.
41. Zhang, Z.-Y., Malachowski, W. P., Van Etten, R. L., and Dixon, J. E. (1994) The nature of the rate-determining steps of the Yersinia protein tyrosine phosphatase-catalyzed reactions, J. Biol. Chem. 269, 8140-8145.
42. Zhang, Z.-Y., Wu, L., and Chen, L. (1995) Transition state and rate-limiting step of the reaction catalyzed by the human dual specificity phosphatase, VHR, Biochemistry 34, 16088-16096.
43. Zhang, Z.-Y. (2003) Mechanistic studies on protein tyrosine phosphatases, Prog. Nucleic Acid Res. Mol. Biol. 73, 171-220.
44. McCain, D. F., Catrina, I. E., Hengge, A. C., and Zhang, Z.-Y. (2002) The catalytic mechanism of Cdc25A phosphatase, J. Biol. Chem. 277, 11190-11200.
45. Chen, L., Montserat, J., Lawrence, D. S., and Zhang, Z.-Y. (1996) VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates, Biochemistry 35, 9349-9354.
46. Gottlin, E. B., Xu, X., Epstein, D. M., Burke, S. P., Eckstein, J. W., Ballow, D. P., and Dixon, J. E. (1996) Kinetic analysis of the catalytic domain of human cdc25B, J. Biol. Chem. 271, 27445-27449
47. Zhou, B., and Zhang, Z.-Y. (1999) Mechanism of mitogen-activated protein kinase phosphatase-3 activation by ERK2, J. Biol. Chem. 274, 35526-35534.
48. Fjeld, C. C., Rice, A. E., Kim, Y., Gee, K. R., and Denu, J. M. (2000) Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase, J. Biol. Chem. 275, 6749-6757.
49. Rudolph, J., Epstein, D. M., Parker, L., and Eckstein, J. (2001) Specificity of natural and artificial substrates for human Cdc25A, Anal. Biochem. 289, 43-51.
50. 5Arg catalytic motif in phosphoester hydrolysis, Biochemistry 33, 15266-15270.
51. Guo, X.-L., Shen, K., Wang, F., Lawrence, D. S., and Zhang, Z.-Y. (2002) Probing the molecular basis for potent and selective protein tyrosine phosphatase 1B inhibition, J. Biol. Chem. 277, 41014-41022.
52. Stewart, A. E., Dowd, S., Keyse, S. M., and McDonald, N. Q. (1999) Crystal structure of the MAPK phosphatase Pyst1 catalytic domain and implications for regulated activation, Nat. Struct. Biol. 6, 174-181.
53. Denu, J. M., and Tanner, K. G. (1998) Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation, Biochemistry 37, 5633-5642.
54. van Montfort, R. L., Congreve, M., Tisi, D., Carr, R., and Jhoti, H. (2003) Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B, Nature 423, 773-737.
55. Salmeen, A., Andersen, J. N., Myers, M. P., Meng, T. C., Hinks, J. A., Tonks, N. K., and Barford, D. (2003) Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate, Nature 423, 769-773.
56. 2, J. Biol. Chem. 277, 20336-20342.
57. Fauman, E. B., Cogswell, J. P., Lovejoy, B., Rocque, W. J., Holmes, W., Montana, V. G., Piwnica-Worms, H., Rink, M. J., and Saper, M. A. (1998) Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A, Cell 93, 617-625.
58. Reynolds, R. A., Yem, A. W., Wolfe, C. L., Deibel, M. R., Jr., Chidester, C. G., and Watenpaugh, K. D. (1999) Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle, J. Mol. Biol. 293, 559-568.
59. Chiarugi, P., Fiaschi, T., Taddei, M. L., Talini, D., Giannoni, E., Raugei, G., and Ramponi, G. (2001) Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation, J. Biol. Chem. 276, 33478-33487.
60. Kosen, P. A. (1992) in Stability of Protein Pharmaceuticals (Ahern, T. J., and Manning, M. C., Eds.) p 34, Plenum Press, New York.
61. Finkel, T. (2003) Oxidant signals and oxidative stress, Curr. Opin. Cell Biol. 15, 247-254.
62. Chiarugi, P., and Cirri, P. (2003) Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction, Trends Biochem. Sci. 28, 509-514.
63. Nicholls, A., and Honig, B. (1991) A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson-Boltzmann equation, J. Comput. Chem. 12, 435-445.